Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Septimiu Murgu

Pulmonary Disease Chicago, IL Medical Doctor

NPI 1881623460 CMS profile 357708

5841 S Maryland Ave, Chicago, IL 60637

Open in the dashboard

General payments

$632,696

614 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$171,352 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Septimiu Murgu of Chicago, IL is reported in the CMS Open Payments database as having received $632,696 across 614 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $171,352 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pulmonary Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,421 27
2024 General $39,495 50
2023 General $70,962 148
2022 General $132,662 83
2021 General $104,640 96
2020 General $65,528 37
2019 General $201,989 173

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Septimiu Murgu
  • Pulmonary Disease median
  • Middle half of Pulmonary Disease
  • National median

In program year 2025, general payments to Septimiu Murgu were reported at $17,421. Among 8,914 Pulmonary Disease profiles paid that year, the median was $500 and the middle half received between $124 and $1,893.

Show as a table
Year Septimiu Murgu Pulmonary Disease median Middle half National median
2019 $201,989 $377 $109–$1,340 $163
2020 $65,528 $230 $56–$907 $114
2021 $104,640 $269 $68–$1,072 $132
2022 $132,662 $390 $100–$1,457 $149
2023 $70,962 $419 $114–$1,659 $160
2024 $39,495 $476 $123–$1,818 $164
2025 $17,421 $500 $124–$1,893 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $209,652 200 payments
  2. Ethicon Inc. $158,224 129 payments
  3. Pinnacle Biologics, Inc $80,913 70 payments
  4. Ethicon Endo-Surgery Inc. $57,848 20 payments
  5. Medical Device Business Services, Inc. $37,314 41 payments
  6. Olympus America Inc. $24,584 26 payments
  7. Olympus Corporation of the Americas $17,236 28 payments
  8. Erbe Elektromedizin GmbH $16,469 4 payments
  9. Medtronic, Inc. $7,568 17 payments
  10. Olympus Medical Systems Corporation $6,922 6 payments
  11. Other $15,966 73 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $353,070 97 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $191,995 62 payments
  3. Travel and Lodging $48,231 175 payments
  4. Education $15,730 15 payments
  5. Food and Beverage $14,024 262 payments
  6. Honoraria $5,246 2 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,400 1 payment
Products named General payments · program years 2019–2025
  1. Monarch Platform Endo-Mechanical $189,759 135 payments
  2. Photofrin $80,913 70 payments
  3. EXPECT $55,922 26 payments
  4. General - Pulmonary $50,973 30 payments
  5. Monarch Platform Endo-Mechanical $35,506 13 payments
  6. Olympus EBUS Bronchoscopes $17,162 28 payments
  7. Olympus Capital Accessories $17,089 27 payments
  8. Olympus Respiratory Accessories $17,089 27 payments
  9. ACQUIRE $16,127 5 payments
  10. Monarch $16,115 9 payments
  11. Other $125,650 204 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$82,997

Medicare's payments for the services billed

Medicare patients

216

Average age 72

Services billed

725

107 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
COPD 49%
Diabetes 47%
Cancer 47%
Ischemic heart disease 45%
Heart failure 41%
Chronic kidney disease 41%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUCALA
  • GlaxoSmithKline, LLC. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

614 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pulmonary Disease in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record